You are not logged in.
Please login to continue selecting trials.
Generic NameRisperidoneProduct NameRISPERDAL®Therapeutic AreaBehaviors and Mental DisordersEnrollment626% Female67.8%% White88%
Product ClassAtypical AntipsychoticsSponsor Protocol NumberRIS-USA-63/CR006022Data PartnerJohnson & JohnsonCondition StudiedDementiaMean/Median Age (Years)82.7
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- Individual-level and study-level predictors of neuropsychiatric symptom placebo response in Alzheimer?s Disease clinical trials
- Symptom severity and minimal clinically important differences for agitation outcome scores in Alzheimer's disease clinical trials
- Consistency checks to improve measurement with the Cohen Mansfield Agitation Inventory (CMAI)
- Temporal trajectories of side-effects associated with antipsychotic treatment ? An individual participant data meta-analysis